主要功效：

 

• 提供可溶性纖維
• 膳食纖維能增進排便的規律性
• 膳食纖維能促進腸道蠕動
• 膳食纖維能增加飽足感 
• 膳食纖維能促進排便順暢

主要成份：

 

左旋麩醯胺酸(L-Glutamine) 1,000毫克

含高蛋白質的食物如肉、魚、豆及奶類產品等都是麩醯胺酸的極佳來源。左旋麩醯胺酸是一種胺基酸，提取自名為麩胺酸(glutamic acid)的另一種胺基酸。大量運動、感染、手術或創傷都會使人體的麩醯胺酸含量減少，尤其是肌肉細胞內的麩醯胺酸。

 

菊糖纖維（菊苣根的低聚果糖萃取物） 5,000毫克

補充益生菌必須先補充益菌素。NutriClean先進纖維粉的菊糖纖維提供八毫克的益菌素。這些種類的益菌素纖維是益菌喜愛的食物來源。菊糖是一種重要的益菌素，存在於蘆筍、菊苣、大蒜、菊芋和洋蔥內。這些食物都提供間接的支援（《營養學期刊》1995年，125期）。菊糖跟果寡糖纖維素(FOS)相似。兩者都是澱粉形態的纖維，人體不能完全消化。當人體食用益菌素時，未能消化的部份為消化道的益菌提供養份。

 

Fibersol-2（水溶性膳食纖維聚合物） 5,000毫克

Fibersol-2是一種可溶性纖維，對清除廢物及淨化消化腸道有正面的效果。透過玉米粉高溫分解及穩定酵素水解而製成的噴霧風乾粉末，造就出如此創新的膳食纖維。Fibersol-2被美國食品藥物管理局(FDA) GRAS評定為「安全」等級的麥芽糊精。麥芽糊精無色，易溶於水。

 

Fibersol的黏性低，水溶性高，吸水度低，溶於水中成為清澈的溶液。由於Fibersol擁有大量天然的化學鍵，因此在消化道中不會被消化，為人體提供許多有益健康的好處。

 

Kazuhiro Ohkuma及Shigeru Wakabayashi在兩人撰寫的一篇研究評論(Advanced Dietary Fibre Technology, 2000)提到Fibersol-2的益處：「其黏合度低於常見的麥芽糊精，雖然兩者有著相同的葡萄糖當量值。Fibersol-2的溶液清透穩定，儲存長時間後仍不會變得混濁或出現沉澱物。Fibersol-2還擁有極佳的抗酸特性，而且在加熱過程中仍保持穩定，因此可以高溫烹煮及消毒。」

 

研究顯示Fibersol-2對人體健康有益。生理學上，Fibersol-2能促進正常規律的腸道活動及排便量。

 

Fibersol-2能輸送至結腸的特定位置。糖份及澱粉混合物的吸收，大部份都在胃部及小腸的前段進行，而Ohkuma及Wakabayashi則假設Fibersol-2避開了在上消化道的消化過程。他們指出：「據估計，百分之九十的Fibersol-2到達大腸，而其中一半被腸道內的細菌所代謝。」

 

基於Fibersol-2對健康的益處及廣泛的用途，它在日本被應用在大量「具有特定健康用途的食品」(Foods for Specified Health Use)。在日本，巿面販售含有Fibersol-2的飲品、餅乾及香腸等產品，並且都標明有促進「腸道規律」的效果。

 

綜合益生菌（嗜乳酸桿菌、胚芽乳酸桿菌、雙歧雙叉桿菌及酪蛋白乳酸桿菌）總菌落數15億                  

益生菌如嗜酸桿菌是特定形式的細菌，亦稱之為「益菌」或「好菌」。事實上，這些細菌有助維持健康的消化道機能。人體的消化系統內有數以百萬計的益菌，以幫助直接消化、改變及轉化食物。益菌量減少是正常的，但仍必須維持在適當的水準，以抵抗其他壞菌，因為如果益菌量下降，其他細菌可能會開始大量孳生。

 

In the News:

-What is inulin? Fiber!          by Karen Rysavy

 

-Fiber May Prevent Colon Cancer After All

2 Studies Contradict Earlier Research Showing No Benefit of Fiber on Colon Cancer Risk

By Sid  Kirchheimer WebMD Medical News

Reviewed By Brunilda  Nazario, MD on Thursday, May 01, 2003

 

 

-Avoiding Digestive and Gastrointestinal Disorders                                                    Source: http://www.safeslimming.co.uk/AvoidingDigestiveGastrointestinalDisorders.cfm

 

-Crohn's Disease and Ulcerative Colitis              by Ronald L. Hoffman, MD, CNS

-TIC launches low-viscosity inulin                                                         2/16/2005 Hydrocolloid supplier TIC Gums has launched an inulin ingredient aimed at boosting the fiber content in a variety of products.

 

-Orafti consolidates science for inulin, oligofructose        by Stephen Daniells in Boston

 

-Fibersol-2 - Brief Article  Prepared Foods,  June, 2001

 

-Fiber Makes Food and Beverages Better (and Healthier)              by Susan Colebank

 

 

-Gut Feeling
If your bowels aren't happy, you won't be either. Here's what's normal and what's not By Patti Woods

Taking Out Toxins                       by Monika Klein, C.N.

 

-Good Gut 'Bugs' Help Irritable Bowel Syndrome

Probiotics Growing into First-Line IBS Treatment

By Daniel DeNoon WebMD Medical News

Reviewed By Brunilda  Nazario, MD on Monday, October 31, 2005

 

 

-Probiotics May Help Stressed Gut

¡¥Good¡¦ Bacteria Might Prevent Intestinal Problems From Chronic Stress

By Miranda Hitti WebMD Medical News

Reviewed By Ann Edmundson, MD on Tuesday, April 25, 2006

Scientific Studies:

 

(L-Glutamine)

• van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. 1993 May 29;341(8857):1363-5.
• Yang C, Li N, Li JS. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol. 2004;10:1992-4.
• Garcia-de-Lorenzo A, Zarazaga A, Garcia-Luna PP, et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition. 2003;19:805-11.

•  Huffman FG, Walgren ME. L-Glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials. 2003;4:324-9. gut integrity. Lancet. 1993;341:1363¡V1365.
• Zoli G, Care M, Falco F, et al. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease [abstract]. Gastroenterology. 1995;108:A766.
• Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. JPEN J Parenter Enteral Nutr.1990;14(suppl 4):109S¡V113S.
•  Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine-supplemented enteral diets. Surg Forum. 1987;38:43¡V44.
• Fujita T, Sakurai K. Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg. 1995;82:749¡V751.
• van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet. 1993;341:1363¡V1365.
• Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr. 2000;30:78¡V84.
• Den Hond E, Hiele M, Peeters M, et al. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. JPEN J Parenter Enteral Nutr. 1999;23:7¡V11.
•  van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet.1993;341:1363¡V1365.
• Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48:28¡V33.
• Shabert JK, Winslow C, Lacey JM, et al. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition. 1999;15:860¡V864.

 

 

(Fibersol-2)

• Satouchi M et al, "Effects of indigestible dextrin on bowel movements," Japanese J Nutr, 51:31-37, 1993.
• Tokunaga K and Matsuoka A, "Effects of a [FOSHU] which contains indigestible dextrin as an effective ingredient on glucose and lipid metabolism," J Japanese Diabetes Society, 42:61-65, 1999.
• Wakabayashi S et al, "Effects of indigestible dextrin on glucose tolerance in rats," J Endocrinology, 144:533-538, 1995.
• Watanabe O et al, "Effects of galacto-oligosaccharide and indigestible dextrin on fat accumulation in broiler," Japanese Poultry Science, 30:35, 1993.

 

 

(Probiotic Blend)

• Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000 Apr;54(4):288-97. 
• Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7.
• Barone C, Pettinato R, Avola E, Alberti A, Greco D, Failla P, Romano C. Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children. Minerva Pediatr. 2000 Mar;52(3):161-5. 
• Bengmark S. Bacteria for optimal health. Nutrition. 2000 Jul-Aug;16(7-8):611-5. 
• Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S5-7.
•  Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998 Jan;42(1):2-7. 
• Biancone L, Pallone F. Current treatment modalities in active Crohn's disease. Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):508-14. 
• Brady LJ, Gallaher DD, Busta FF. The role of probiotic cultures in the prevention of colon cancer. J Nutr. 2000 Feb;130(2S Suppl):410S-414S.
• Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S18-22.
• Cerrato PL. Can "healthy" bacteria ward off disease? RN. 2000 Apr;63(4):71-4. 
• Chin J, Turner B, Barchia I, Mullbacher A. Immune response to orally consumed antigens and probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):55-66.
• Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999 May;69(5):1052S-1057S.
• Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, Califano C, Dunn AM, Grassey C, Hinds G, Cervia J. Probiotics and immune response. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S22-5.
• D'Argenio G, Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol. 1999;472:149-58.
• Davidson GP, Butler RN. Probiotics in pediatric gastrointestinal disorders. Curr Opin Pediatr. 2000 Oct;12(5):477-81.
• de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000 Feb;71(2):405-11. 
• Dugas B, Mercenier A, Lenoir-Wijnkoop I, Arnaud C, Dugas N, Postaire E. Immunity and probiotics. Immunol Today. 1999 Sep;20(9):387-90.
• Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):279-92. 
• Dupont C. Bacterial flora in the infant and intestinal immunity: Implication and prospects for infant food with probiotics. Arch Pediatr. 2000 May;7 Suppl 2:252s-255s.
• Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr. 2000 Feb;130(2S Suppl):403S-409S. 
• Folwaczny C. Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment? Z Gastroenterol. 2000 Jun;38(6):547-50.
• Friedrich MJ. A bit of culture for children: probiotics may improve health and fight disease. JAMA. 2000 Sep 20;284(11):1365-6. 
• Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr. 2000 Feb;130(2S Suppl):391S-395S.
• Gibson GR, McCartney AL. Modification of the gut flora by dietary means. Biochem Soc Trans. 1998 May;26(2):222-8.
• Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents. 1999 Aug;12(4):287-92.
• Goldin BR. Health benefits of probiotics. Br J Nutr. 1998 Oct;80(4):S203-7.
• Gomez-Gil B, Roque A, Turnbull JF, Inglis V. A review on the use of microorganisms as probiotics. Rev Latinoam Microbiol. 1998 Jul-Dec;40(3-4):166-72.
• Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S2-4.
• Guslandi M. The relationship between gut microflora and intestinal inflammation. Can J Gastroenterol. 2000 Jan;14(1):32.
• Heyman M. Effect of lactic acid bacteria on diarrheal diseases. J Am Coll Nutr. 2000 Apr;19(2 Suppl):137S-146S.
• Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000 May;2(6):681-6.
• Hoerr RA, Bostwick EF. Bioactive proteins and probiotic bacteria: modulators of nutritional health. Nutrition. 2000 Jul-Aug;16(7-8):711-3.
• Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol. 1998 May 26;41(2):85-101.
• Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr. 1999 May;53(5):339-50.
• Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999 Summer;3(4):197-202. 
• Isolauri E. The use of probiotics in paediatrics. Hosp Med. 2000 Jan;61(1):6-7. 
• Kasper H. Protection against gastrointestinal diseases--present facts and future developments. Int J Food Microbiol. 1998 May 26;41(2):127-31.
• Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics--a novel approach in the management of food allergy. Allergy. 1999 Sep;54(9):909-15.
• Klaenhammer TR. Probiotic bacteria: today and tomorrow. J Nutr. 2000 Feb;130(2S Suppl):415S-416S. 40. Kochhar KP. Probiotics and gastrointestinal function in health and disease. Trop Gastroenterol. 2000 Jan-Mar;21(1):8-11.
• LaMont JT. The renaissance of probiotics and prebiotics. Gastroenterology. 2000 Aug;119(2):291.
• Levy J. Immunonutrition: the pediatric experience. Nutrition. 1998 Jul-Aug;14(7-8):641-7. 43. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999 Apr 10;318(7189):999-1003.
• Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):67-73.
• Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res. 2000;26(3):95-111.
• Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol. 2000 Jan;30(1):10-3.
• Reddy BS. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr. 1999 Jul;129(7 Suppl):1478S-82S.
• Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol. 1999 Sep;65(9):3763-6.
• Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S.
• Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000 Feb;130(2S Suppl):396S-402S.
• Saavedra JM. Probiotics plus antibiotics: regulating our bacterial environment. J Pediatr. 1999 Nov;135(5):535-7.
• Sanders ME. Considerations for use of probiotic bacteria to modulate human health. J Nutr. 2000 Feb;130(2S Suppl):384S-390S.
• Shanahan F. Immunology. Therapeutic manipulation of gut flora. Science. 2000 Aug 25;289(5483):1311-2.
• Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis. 2000 May;6(2):107-15.
• Studd C. Probiotic containing fermented milk supplement may improve the institution of early enteral nutrition. Crit Care Med. 2000 Apr;28(4):1255-6.
• Szilagyi A. Prebiotics or probiotics for lactose intolerance: a question of adaptation. Am J Clin Nutr. 1999 Jul;70(1):105-6.
• Taylor GR, Williams CM. Effects of probiotics and prebiotics on blood lipids. Br J Nutr. 1998 Oct;80(4):S225-30. 
• Torrens JK, McWhinney PH. Probiotics and life-threatening infection. J Infect. 1999 Nov;39(3):246.
• Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov;135(5):564-8.
• Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):323-32.
• Vanderhoof JA. Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S34-8.
• Vilpponen-Salmela T, Alander M, Satokari R, Bjorkman P, Kontula P, Korpela R, Saxelin M, Mattila-Sandholm T, von Wright A. Probiotic bacteria and intestinal health: new methods of investigation. J Physiol Paris. 2000 Mar-Apr;94(2):157-8.
• von Wright A, Salminen S. Probiotics: established effects and open questions. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1195-8.
• Yasui H, Shida K, Matsuzaki T, Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):383-9.
• Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Gopal PK, Gill HS. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol. 2000 Feb-Mar;38(2-3):153-61.

 

 

(Inulin)

• Davidson MH, Synecki C, Maki KC, Drennen KB. Effects of dietary inulin in serum lipids in men and women with hypercholesterolaemia. Nutr Res. 1998;3:503¡V17.
• Giacco R, Clemente G, Luongo D, et al. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr. 2004;23:331¡V40.
• Jackson KG, Taylor GRJ, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr. 1999;82:23¡V30.
• Pedersen A, Sandstrom B, van Amelsvoort JMM. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr. 1997;78:215¡V22.
• Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr. 1998;52:436¡V40.
• van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr. 99;53:1¡V7.
• Williams CM, Jackson KG. Inulin and oligofructose: effects on lipid metabolism from human studies. Br J Nutr. 2002;87(suppl 2):S261¡V4.
• Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther. 2001;15:1139¡V1145.
• Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr. 2000;72:1570¡V5.
• Tahiri M, Tressol JC, Arnaud J, et al. Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res. 2001;16:2152¡V2160.
• Tahiri M, Tressol JC, Arnaud J, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am J Clin Nutr. 2003;77:449¡V457.
• Ducros V, Arnaud J, Tahiri M, et al. Influence of short-chain fructo-oligosaccharides (sc-FOS) on absorption of Cu, Zn, and Se in healthy postmenopausal women. J Am Coll Nutr. 2005;24:30¡V7.
• Waligora-Dupriet AJ, Campeotto F, Nicolis I et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol. 2006 Sep 20 [Epub ahead of print]
• Brighenti F, Casiraghi MC, Canzi E, Ferrari A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. 1999; 53:726-733.
• Menne E, Guggenbuhl N, Roberfroid M. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr. 2000; 130:1197-1199.
• Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis. 1997; 18:1371-1374.
• Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr. 1998; 18:117-143.
• Roberfroid MB, Van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998; 128:11-19.
• Williams CM. Effects of inulin on lipid parameters in humans. J Nutr. 1999; 129(7 Suppl):1471S-1473S.

      NutriClean™先進纖維粉為何與眾不同？

 

NutriClean™系列產品中的 NutriClean 先進纖維粉有可口的莓果味道，口感極佳，極易與水混合。本品配方含有可溶纖維質，益菌素(prebiotics)，有助於健康的益生菌(probiotics)以及必需的胃腸營養素。結腸是消化系統的排泄主要重點，也是整體消化系統健康與否的主要決定因素。含有益生菌的先進纖維粉配方，可達到改變細菌叢生態，使腸內菌相平衡、健康維持。美安臺灣公司的 NutriClean 先進纖維粉不但提供優質的可溶性纖維質，且富含有益保健的益生菌(probiotics)，能增加腸道內好菌的數量，維持腸內微生物體的平衡。除此之外，在其他唯一可發現益生菌的地方是優格(yogurt)和克弗爾(kefir)等食品中。經過美安公司科學家的研究證明，NutriClean 先進纖維粉含有左旋麩醯胺酸(L-Glutamine)、菊糖纖維(Inulin Fiber)、可溶性膳食纖維Fibersol-2和益生菌，是對人體最有益的保健配方。本產品中所含的益生菌配方，能提供15億菌落數的健康微生物！眾所皆知，理想的健康從身體內部的清潔開始，而先進纖維粉能助您一臂之力，實現體內環保的理想！ 

常見問題：

 

為何消化道的保健如此重要？

很少人真正留意消化道的健康，直到身體出現警訊，使人們正視消化道保健的重要性。眾

所周知，充足的纖維與益生菌能幫助維持消化道機能，改變細菌叢生態，並能使排便順

暢。即使這些剩餘食物殘渣產生了毒素和細菌，也能被快速排除而不至於影響健康。

 

NutriClean™先進纖維粉和一般市售的纖維粉有何不同？

NutriClean™先進纖維粉是維持消化道健康的革命性創新產品。美安台灣的NutriClean先進纖維粉跨出的不是一小步，而是一大步，藉此確保消化腸道的正常運作。NutriClean纖維粉內含左旋麩醯胺酸(L-Glutamine)，菊糖纖維和可溶性膳食纖維Fibersol-2，以及15億益生菌微生物，可幫助改變細菌叢生態，進而維護整體健康。

 

為什麼纖維對整體健康如此重要？

現代人並未從飲食中攝取足夠的纖維，纖維應該是飲食中最重要的營養之一，卻往往被人

們忽略了。纖維的益處包括促進腸道蠕動、增加飽足感、促進排便、維持腸道運作的規律性與健康的腸道菌叢生態（益菌的食物）。此外，膳食纖維可增加排便量。

 

可溶性膳食纖維Fibersol-2是什麼？

Fibersol-2是市面上新一代的纖維。這種Fibersol-2是從玉米提取的可溶性膳食纖維，不會進入血液中，消化過程可保持完整，進而能在消化道的後段部份發揮作用，同時它具有上述纖維的所有好處。許多國際研究指出，可溶性膳食纖維Fibersol-2已經科學研究證明擁有卓越的效果。對於以加工食品為典型飲食的現代人而言，是一大福音。

 

 益生菌(probiotics)是什麼？

益生菌(probiotics)是一種細菌。NutriClean™先進纖維粉配方中所含的益生菌能幫助維持細菌叢生態，為理想的整體健康鋪路。研究發現，食用益生菌有益於維持理想的消化機能。幾世紀以來，世界各地的文化（諸如喬治亞、亞塞拜然、厄瓜多和喜馬拉雅山脈地帶），已廣泛使用各種不同種類的健康菌叢（益生菌）來維持身體的健康。益生菌的每次攝取量須超過10億菌落數方能發揮作用，且須規律性按時食用。每一份量的NutriClean先進纖維粉配方含有15億菌落數的益生菌，其中包括嗜乳酸桿菌(Lactobacillus acidophilus)、胚芽乳酸桿菌(Lactobacillus plantarum)、酪蛋白乳酸桿菌(Lactobacillus casei) 以及雙歧雙叉桿菌(Bifodobacterium bifidum)。

 

如何飲用NutriClean™先進纖維粉？

睡前，盛一匙的NutriClean先進纖維粉加入一杯237毫升的冷開水，攪拌均勻後飲用。一天食用一匙美安台灣的NutriClean先進纖維粉，即可提供9公克每日所需的纖維，以補充日常飲食的不足。

 

為什麼NutriClean™先進纖維粉的產品説明中建議在晚上睡前飲用？有經銷商反映會造成半夜起來如厠的困擾。是否有其他解決的方法?

你可以在任何你覺得方便的時間飲用NutriClean先進纖維粉。建議在睡前飲用，是因為這樣可以利用晚上睡眠時讓身體自然進行清潔程序。

 

  點擊此處檢視產品標籤

主要功效：

 

• 提供可溶性纖維
• 膳食纖維能增進排便的規律性
• 膳食纖維能促進腸道蠕動
• 膳食纖維能增加飽足感 
• 膳食纖維能促進排便順暢

主要成份：

 

左旋麩醯胺酸(L-Glutamine) 1,000毫克

含高蛋白質的食物如肉、魚、豆及奶類產品等都是麩醯胺酸的極佳來源。左旋麩醯胺酸是一種胺基酸，提取自名為麩胺酸(glutamic acid)的另一種胺基酸。大量運動、感染、手術或創傷都會使人體的麩醯胺酸含量減少，尤其是肌肉細胞內的麩醯胺酸。

 

菊糖纖維（菊苣根的低聚果糖萃取物） 5,000毫克

補充益生菌必須先補充益菌素。NutriClean先進纖維粉的菊糖纖維提供八毫克的益菌素。這些種類的益菌素纖維是益菌喜愛的食物來源。菊糖是一種重要的益菌素，存在於蘆筍、菊苣、大蒜、菊芋和洋蔥內。這些食物都提供間接的支援（《營養學期刊》1995年，125期）。菊糖跟果寡糖纖維素(FOS)相似。兩者都是澱粉形態的纖維，人體不能完全消化。當人體食用益菌素時，未能消化的部份為消化道的益菌提供養份。

 

Fibersol-2（水溶性膳食纖維聚合物） 5,000毫克

Fibersol-2是一種可溶性纖維，對清除廢物及淨化消化腸道有正面的效果。透過玉米粉高溫分解及穩定酵素水解而製成的噴霧風乾粉末，造就出如此創新的膳食纖維。Fibersol-2被美國食品藥物管理局(FDA) GRAS評定為「安全」等級的麥芽糊精。麥芽糊精無色，易溶於水。

 

Fibersol的黏性低，水溶性高，吸水度低，溶於水中成為清澈的溶液。由於Fibersol擁有大量天然的化學鍵，因此在消化道中不會被消化，為人體提供許多有益健康的好處。

 

Kazuhiro Ohkuma及Shigeru Wakabayashi在兩人撰寫的一篇研究評論(Advanced Dietary Fibre Technology, 2000)提到Fibersol-2的益處：「其黏合度低於常見的麥芽糊精，雖然兩者有著相同的葡萄糖當量值。Fibersol-2的溶液清透穩定，儲存長時間後仍不會變得混濁或出現沉澱物。Fibersol-2還擁有極佳的抗酸特性，而且在加熱過程中仍保持穩定，因此可以高溫烹煮及消毒。」

 

研究顯示Fibersol-2對人體健康有益。生理學上，Fibersol-2能促進正常規律的腸道活動及排便量。

 

Fibersol-2能輸送至結腸的特定位置。糖份及澱粉混合物的吸收，大部份都在胃部及小腸的前段進行，而Ohkuma及Wakabayashi則假設Fibersol-2避開了在上消化道的消化過程。他們指出：「據估計，百分之九十的Fibersol-2到達大腸，而其中一半被腸道內的細菌所代謝。」

 

基於Fibersol-2對健康的益處及廣泛的用途，它在日本被應用在大量「具有特定健康用途的食品」(Foods for Specified Health Use)。在日本，巿面販售含有Fibersol-2的飲品、餅乾及香腸等產品，並且都標明有促進「腸道規律」的效果。

 

綜合益生菌（嗜乳酸桿菌、胚芽乳酸桿菌、雙歧雙叉桿菌及酪蛋白乳酸桿菌）總菌落數15億                  

益生菌如嗜酸桿菌是特定形式的細菌，亦稱之為「益菌」或「好菌」。事實上，這些細菌有助維持健康的消化道機能。人體的消化系統內有數以百萬計的益菌，以幫助直接消化、改變及轉化食物。益菌量減少是正常的，但仍必須維持在適當的水準，以抵抗其他壞菌，因為如果益菌量下降，其他細菌可能會開始大量孳生。

 

In the News:

-What is inulin? Fiber!          by Karen Rysavy

 

-Fiber May Prevent Colon Cancer After All

2 Studies Contradict Earlier Research Showing No Benefit of Fiber on Colon Cancer Risk

By Sid  Kirchheimer WebMD Medical News

Reviewed By Brunilda  Nazario, MD on Thursday, May 01, 2003

 

 

-Avoiding Digestive and Gastrointestinal Disorders                                                    Source: http://www.safeslimming.co.uk/AvoidingDigestiveGastrointestinalDisorders.cfm

 

-Crohn's Disease and Ulcerative Colitis              by Ronald L. Hoffman, MD, CNS

-TIC launches low-viscosity inulin                                                         2/16/2005 Hydrocolloid supplier TIC Gums has launched an inulin ingredient aimed at boosting the fiber content in a variety of products.

 

-Orafti consolidates science for inulin, oligofructose        by Stephen Daniells in Boston

 

-Fibersol-2 - Brief Article  Prepared Foods,  June, 2001

 

-Fiber Makes Food and Beverages Better (and Healthier)              by Susan Colebank

 

 

-Gut Feeling
If your bowels aren't happy, you won't be either. Here's what's normal and what's not By Patti Woods

Taking Out Toxins                       by Monika Klein, C.N.

 

-Good Gut 'Bugs' Help Irritable Bowel Syndrome

Probiotics Growing into First-Line IBS Treatment

By Daniel DeNoon WebMD Medical News

Reviewed By Brunilda  Nazario, MD on Monday, October 31, 2005

 

 

-Probiotics May Help Stressed Gut

¡¥Good¡¦ Bacteria Might Prevent Intestinal Problems From Chronic Stress

By Miranda Hitti WebMD Medical News

Reviewed By Ann Edmundson, MD on Tuesday, April 25, 2006

Scientific Studies:

 

(L-Glutamine)

• van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. 1993 May 29;341(8857):1363-5.
• Yang C, Li N, Li JS. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol. 2004;10:1992-4.
• Garcia-de-Lorenzo A, Zarazaga A, Garcia-Luna PP, et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition. 2003;19:805-11.

•  Huffman FG, Walgren ME. L-Glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials. 2003;4:324-9. gut integrity. Lancet. 1993;341:1363¡V1365.
• Zoli G, Care M, Falco F, et al. Effect of oral glutamine on intestinal permeability and nutritional status in Crohn's disease [abstract]. Gastroenterology. 1995;108:A766.
• Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. JPEN J Parenter Enteral Nutr.1990;14(suppl 4):109S¡V113S.
•  Fox AD, Kripke SA, Berman JR, et al. Reduction of the severity of enterocolitis by glutamine-supplemented enteral diets. Surg Forum. 1987;38:43¡V44.
• Fujita T, Sakurai K. Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg. 1995;82:749¡V751.
• van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet. 1993;341:1363¡V1365.
• Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr. 2000;30:78¡V84.
• Den Hond E, Hiele M, Peeters M, et al. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. JPEN J Parenter Enteral Nutr. 1999;23:7¡V11.
•  van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet.1993;341:1363¡V1365.
• Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001;48:28¡V33.
• Shabert JK, Winslow C, Lacey JM, et al. Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial. Nutrition. 1999;15:860¡V864.

 

 

(Fibersol-2)

• Satouchi M et al, "Effects of indigestible dextrin on bowel movements," Japanese J Nutr, 51:31-37, 1993.
• Tokunaga K and Matsuoka A, "Effects of a [FOSHU] which contains indigestible dextrin as an effective ingredient on glucose and lipid metabolism," J Japanese Diabetes Society, 42:61-65, 1999.
• Wakabayashi S et al, "Effects of indigestible dextrin on glucose tolerance in rats," J Endocrinology, 144:533-538, 1995.
• Watanabe O et al, "Effects of galacto-oligosaccharide and indigestible dextrin on fat accumulation in broiler," Japanese Poultry Science, 30:35, 1993.

 

 

(Probiotic Blend)

• Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000 Apr;54(4):288-97. 
• Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr. 2000 Mar;54(3):263-7.
• Barone C, Pettinato R, Avola E, Alberti A, Greco D, Failla P, Romano C. Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children. Minerva Pediatr. 2000 Mar;52(3):161-5. 
• Bengmark S. Bacteria for optimal health. Nutrition. 2000 Jul-Aug;16(7-8):611-5. 
• Bengmark S. Colonic food: pre- and probiotics. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S5-7.
•  Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998 Jan;42(1):2-7. 
• Biancone L, Pallone F. Current treatment modalities in active Crohn's disease. Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):508-14. 
• Brady LJ, Gallaher DD, Busta FF. The role of probiotic cultures in the prevention of colon cancer. J Nutr. 2000 Feb;130(2S Suppl):410S-414S.
• Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S18-22.
• Cerrato PL. Can "healthy" bacteria ward off disease? RN. 2000 Apr;63(4):71-4. 
• Chin J, Turner B, Barchia I, Mullbacher A. Immune response to orally consumed antigens and probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):55-66.
• Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999 May;69(5):1052S-1057S.
• Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, Califano C, Dunn AM, Grassey C, Hinds G, Cervia J. Probiotics and immune response. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S22-5.
• D'Argenio G, Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol. 1999;472:149-58.
• Davidson GP, Butler RN. Probiotics in pediatric gastrointestinal disorders. Curr Opin Pediatr. 2000 Oct;12(5):477-81.
• de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr. 2000 Feb;71(2):405-11. 
• Dugas B, Mercenier A, Lenoir-Wijnkoop I, Arnaud C, Dugas N, Postaire E. Immunity and probiotics. Immunol Today. 1999 Sep;20(9):387-90.
• Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):279-92. 
• Dupont C. Bacterial flora in the infant and intestinal immunity: Implication and prospects for infant food with probiotics. Arch Pediatr. 2000 May;7 Suppl 2:252s-255s.
• Erickson KL, Hubbard NE. Probiotic immunomodulation in health and disease. J Nutr. 2000 Feb;130(2S Suppl):403S-409S. 
• Folwaczny C. Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment? Z Gastroenterol. 2000 Jun;38(6):547-50.
• Friedrich MJ. A bit of culture for children: probiotics may improve health and fight disease. JAMA. 2000 Sep 20;284(11):1365-6. 
• Gibson GR, Fuller R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J Nutr. 2000 Feb;130(2S Suppl):391S-395S.
• Gibson GR, McCartney AL. Modification of the gut flora by dietary means. Biochem Soc Trans. 1998 May;26(2):222-8.
• Gismondo MR, Drago L, Lombardi A. Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents. 1999 Aug;12(4):287-92.
• Goldin BR. Health benefits of probiotics. Br J Nutr. 1998 Oct;80(4):S203-7.
• Gomez-Gil B, Roque A, Turnbull JF, Inglis V. A review on the use of microorganisms as probiotics. Rev Latinoam Microbiol. 1998 Jul-Dec;40(3-4):166-72.
• Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol. 2000 Jan;95(1 Suppl):S2-4.
• Guslandi M. The relationship between gut microflora and intestinal inflammation. Can J Gastroenterol. 2000 Jan;14(1):32.
• Heyman M. Effect of lactic acid bacteria on diarrheal diseases. J Am Coll Nutr. 2000 Apr;19(2 Suppl):137S-146S.
• Hirayama K, Rafter J. The role of probiotic bacteria in cancer prevention. Microbes Infect. 2000 May;2(6):681-6.
• Hoerr RA, Bostwick EF. Bioactive proteins and probiotic bacteria: modulators of nutritional health. Nutrition. 2000 Jul-Aug;16(7-8):711-3.
• Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol. 1998 May 26;41(2):85-101.
• Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr. 1999 May;53(5):339-50.
• Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis. 1999 Summer;3(4):197-202. 
• Isolauri E. The use of probiotics in paediatrics. Hosp Med. 2000 Jan;61(1):6-7. 
• Kasper H. Protection against gastrointestinal diseases--present facts and future developments. Int J Food Microbiol. 1998 May 26;41(2):127-31.
• Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics--a novel approach in the management of food allergy. Allergy. 1999 Sep;54(9):909-15.
• Klaenhammer TR. Probiotic bacteria: today and tomorrow. J Nutr. 2000 Feb;130(2S Suppl):415S-416S. 40. Kochhar KP. Probiotics and gastrointestinal function in health and disease. Trop Gastroenterol. 2000 Jan-Mar;21(1):8-11.
• LaMont JT. The renaissance of probiotics and prebiotics. Gastroenterology. 2000 Aug;119(2):291.
• Levy J. Immunonutrition: the pediatric experience. Nutrition. 1998 Jul-Aug;14(7-8):641-7. 43. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999 Apr 10;318(7189):999-1003.
• Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol. 2000 Feb;78(1):67-73.
• Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res. 2000;26(3):95-111.
• Ouwehand AC, Isolauri E, Kirjavainen PV, Tolkko S, Salminen SJ. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol. 2000 Jan;30(1):10-3.
• Reddy BS. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr. 1999 Jul;129(7 Suppl):1478S-82S.
• Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol. 1999 Sep;65(9):3763-6.
• Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S.
• Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000 Feb;130(2S Suppl):396S-402S.
• Saavedra JM. Probiotics plus antibiotics: regulating our bacterial environment. J Pediatr. 1999 Nov;135(5):535-7.
• Sanders ME. Considerations for use of probiotic bacteria to modulate human health. J Nutr. 2000 Feb;130(2S Suppl):384S-390S.
• Shanahan F. Immunology. Therapeutic manipulation of gut flora. Science. 2000 Aug 25;289(5483):1311-2.
• Shanahan F. Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm Bowel Dis. 2000 May;6(2):107-15.
• Studd C. Probiotic containing fermented milk supplement may improve the institution of early enteral nutrition. Crit Care Med. 2000 Apr;28(4):1255-6.
• Szilagyi A. Prebiotics or probiotics for lactose intolerance: a question of adaptation. Am J Clin Nutr. 1999 Jul;70(1):105-6.
• Taylor GR, Williams CM. Effects of probiotics and prebiotics on blood lipids. Br J Nutr. 1998 Oct;80(4):S225-30. 
• Torrens JK, McWhinney PH. Probiotics and life-threatening infection. J Infect. 1999 Nov;39(3):246.
• Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999 Nov;135(5):564-8.
• Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):323-32.
• Vanderhoof JA. Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr. 2000;30 Suppl 2:S34-8.
• Vilpponen-Salmela T, Alander M, Satokari R, Bjorkman P, Kontula P, Korpela R, Saxelin M, Mattila-Sandholm T, von Wright A. Probiotic bacteria and intestinal health: new methods of investigation. J Physiol Paris. 2000 Mar-Apr;94(2):157-8.
• von Wright A, Salminen S. Probiotics: established effects and open questions. Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1195-8.
• Yasui H, Shida K, Matsuzaki T, Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek. 1999 Jul-Nov;76(1-4):383-9.
• Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Gopal PK, Gill HS. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol. 2000 Feb-Mar;38(2-3):153-61.

 

 

(Inulin)

• Davidson MH, Synecki C, Maki KC, Drennen KB. Effects of dietary inulin in serum lipids in men and women with hypercholesterolaemia. Nutr Res. 1998;3:503¡V17.
• Giacco R, Clemente G, Luongo D, et al. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr. 2004;23:331¡V40.
• Jackson KG, Taylor GRJ, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr. 1999;82:23¡V30.
• Pedersen A, Sandstrom B, van Amelsvoort JMM. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr. 1997;78:215¡V22.
• Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr. 1998;52:436¡V40.
• van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EG. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr. 99;53:1¡V7.
• Williams CM, Jackson KG. Inulin and oligofructose: effects on lipid metabolism from human studies. Br J Nutr. 2002;87(suppl 2):S261¡V4.
• Cummings JH, Christie S, Cole TJ. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther. 2001;15:1139¡V1145.
• Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr. 2000;72:1570¡V5.
• Tahiri M, Tressol JC, Arnaud J, et al. Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res. 2001;16:2152¡V2160.
• Tahiri M, Tressol JC, Arnaud J, et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am J Clin Nutr. 2003;77:449¡V457.
• Ducros V, Arnaud J, Tahiri M, et al. Influence of short-chain fructo-oligosaccharides (sc-FOS) on absorption of Cu, Zn, and Se in healthy postmenopausal women. J Am Coll Nutr. 2005;24:30¡V7.
• Waligora-Dupriet AJ, Campeotto F, Nicolis I et al. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol. 2006 Sep 20 [Epub ahead of print]
• Brighenti F, Casiraghi MC, Canzi E, Ferrari A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. 1999; 53:726-733.
• Menne E, Guggenbuhl N, Roberfroid M. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J Nutr. 2000; 130:1197-1199.
• Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis. 1997; 18:1371-1374.
• Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr. 1998; 18:117-143.
• Roberfroid MB, Van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998; 128:11-19.
• Williams CM. Effects of inulin on lipid parameters in humans. J Nutr. 1999; 129(7 Suppl):1471S-1473S.

      NutriClean™先進纖維粉為何與眾不同？

 

NutriClean™系列產品中的 NutriClean 先進纖維粉有可口的莓果味道，口感極佳，極易與水混合。本品配方含有可溶纖維質，益菌素(prebiotics)，有助於健康的益生菌(probiotics)以及必需的胃腸營養素。結腸是消化系統的排泄主要重點，也是整體消化系統健康與否的主要決定因素。含有益生菌的先進纖維粉配方，可達到改變細菌叢生態，使腸內菌相平衡、健康維持。美安臺灣公司的 NutriClean 先進纖維粉不但提供優質的可溶性纖維質，且富含有益保健的益生菌(probiotics)，能增加腸道內好菌的數量，維持腸內微生物體的平衡。除此之外，在其他唯一可發現益生菌的地方是優格(yogurt)和克弗爾(kefir)等食品中。經過美安公司科學家的研究證明，NutriClean 先進纖維粉含有左旋麩醯胺酸(L-Glutamine)、菊糖纖維(Inulin Fiber)、可溶性膳食纖維Fibersol-2和益生菌，是對人體最有益的保健配方。本產品中所含的益生菌配方，能提供15億菌落數的健康微生物！眾所皆知，理想的健康從身體內部的清潔開始，而先進纖維粉能助您一臂之力，實現體內環保的理想！ 

常見問題：

 

為何消化道的保健如此重要？

很少人真正留意消化道的健康，直到身體出現警訊，使人們正視消化道保健的重要性。眾

所周知，充足的纖維與益生菌能幫助維持消化道機能，改變細菌叢生態，並能使排便順

暢。即使這些剩餘食物殘渣產生了毒素和細菌，也能被快速排除而不至於影響健康。

 

NutriClean™先進纖維粉和一般市售的纖維粉有何不同？

NutriClean™先進纖維粉是維持消化道健康的革命性創新產品。美安台灣的NutriClean先進纖維粉跨出的不是一小步，而是一大步，藉此確保消化腸道的正常運作。NutriClean纖維粉內含左旋麩醯胺酸(L-Glutamine)，菊糖纖維和可溶性膳食纖維Fibersol-2，以及15億益生菌微生物，可幫助改變細菌叢生態，進而維護整體健康。

 

為什麼纖維對整體健康如此重要？

現代人並未從飲食中攝取足夠的纖維，纖維應該是飲食中最重要的營養之一，卻往往被人

們忽略了。纖維的益處包括促進腸道蠕動、增加飽足感、促進排便、維持腸道運作的規律性與健康的腸道菌叢生態（益菌的食物）。此外，膳食纖維可增加排便量。

 

可溶性膳食纖維Fibersol-2是什麼？

Fibersol-2是市面上新一代的纖維。這種Fibersol-2是從玉米提取的可溶性膳食纖維，不會進入血液中，消化過程可保持完整，進而能在消化道的後段部份發揮作用，同時它具有上述纖維的所有好處。許多國際研究指出，可溶性膳食纖維Fibersol-2已經科學研究證明擁有卓越的效果。對於以加工食品為典型飲食的現代人而言，是一大福音。

 

 益生菌(probiotics)是什麼？

益生菌(probiotics)是一種細菌。NutriClean™先進纖維粉配方中所含的益生菌能幫助維持細菌叢生態，為理想的整體健康鋪路。研究發現，食用益生菌有益於維持理想的消化機能。幾世紀以來，世界各地的文化（諸如喬治亞、亞塞拜然、厄瓜多和喜馬拉雅山脈地帶），已廣泛使用各種不同種類的健康菌叢（益生菌）來維持身體的健康。益生菌的每次攝取量須超過10億菌落數方能發揮作用，且須規律性按時食用。每一份量的NutriClean先進纖維粉配方含有15億菌落數的益生菌，其中包括嗜乳酸桿菌(Lactobacillus acidophilus)、胚芽乳酸桿菌(Lactobacillus plantarum)、酪蛋白乳酸桿菌(Lactobacillus casei) 以及雙歧雙叉桿菌(Bifodobacterium bifidum)。

 

如何飲用NutriClean™先進纖維粉？

睡前，盛一匙的NutriClean先進纖維粉加入一杯237毫升的冷開水，攪拌均勻後飲用。一天食用一匙美安台灣的NutriClean先進纖維粉，即可提供9公克每日所需的纖維，以補充日常飲食的不足。

 

為什麼NutriClean™先進纖維粉的產品説明中建議在晚上睡前飲用？有經銷商反映會造成半夜起來如厠的困擾。是否有其他解決的方法?

你可以在任何你覺得方便的時間飲用NutriClean先進纖維粉。建議在睡前飲用，是因為這樣可以利用晚上睡眠時讓身體自然進行清潔程序。